recall
Alert: Edwards Lifesciences Swan-Ganz Thermodilution Catheter
Incorrect assembly causing reversal of lumens
recall
Alert: Smiths Medical sterile saline and sterile water products for inhalation
Potential exposure to infectious agents (bacillus infantis and staphylococcus epidermidis)
recall
Alert: Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP (Expanded Recall)
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Irbesartan and Irbesartan HCTZ Tablets
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g
Presence of visual grey particulate matter in reconstituted vials
recall
Alert: Losartan Potassium Tablets, USP (Expanded Recall)
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP
Presence of probable human carcinogen N-nitrosodiethylamine
recall
Alert: Losartan Potassium Tablets, USP
Due to presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Dyural-40 and Dyural-80 Convenience Kits
Product labeling incorrectly stating stoppers do not contain latex.
recall
Alert: Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP (Expanded recall)
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets
Presence above specification limits of probable carcinogen N-nitroso-diethylamine
recall
Alert: Sodium Chloride Injection, USP, 0.9%
Product labeling incorrectly stating stoppers do not contain Latex (The stoppers contain natural rubber latex.)
recall
Alert: Amlodipine and Valsartan Tablets, USP; Valsartan Tablets, USP; and Valsartan and Hydrochlorothiazide Tablets, USP
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Westminster Pharmaceuticals Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Golden State Medical Supply Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Robaxin methocarbamol tablets, USP
Incorrect daily dosing information on the label due to labeling error
recall
Alert: Isoxazoline Flea and Tick Products
Potential for neurologic adverse events in dogs and cats
